Cargando…

Nerve Sheath Tumors in Neurofibromatosis Type 1: Assessment of Whole-Body Metabolic Tumor Burden Using F-18-FDG PET/CT

PURPOSE: To determine the metabolically active whole-body tumor volume (WB-MTV) on F-18-fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) in individuals with neurofibromatosis type 1 (NF1) using a three-dimensional (3D) segmentation and computerized volumetry tech...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salamon, Johannes, Papp, László, Tóth, Zoltán, Laqmani, Azien, Apostolova, Ivayla, Adam, Gerhard, Mautner, Victor F., Derlin, Thorsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666520/ https://www.ncbi.nlm.nih.gov/pubmed/26625155 http://dx.doi.org/10.1371/journal.pone.0143305

Ejemplares similares

Structural alteration of lung parenchyma in patients with NF1: a phenotyping study using multidetector computed tomography (MDCT)
por: Avanesov, Maxim, et al.
Publicado: (2021)

Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1
por: Thomas, Laura, et al.
Publicado: (2012)

Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth
por: Well, Lennart, et al.
Publicado: (2021)

Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1
por: Ristow, Inka, et al.
Publicado: (2022)

Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors
por: Park, Su-Jin, et al.
Publicado: (2013)

An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET
por: Hofheinz, Frank, et al.
Publicado: (2016)

The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1
por: Well, Lennart, et al.
Publicado: (2020)

Diagnostic value of (18)F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients
por: Geitenbeek, Ritch T. J., et al.
Publicado: (2022)

Comparative evaluation of SUV, tumor-to-blood standard uptake ratio (SUR), and dual time point measurements for assessment of the metabolic uptake rate in FDG PET
por: Hofheinz, Frank, et al.
Publicado: (2016)

Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of (18)F-FDG PET
por: Cook, Gary J. R., et al.
Publicado: (2017)

Effector T cell subclasses associate with tumor burden in neurofibromatosis type 1 patients
por: Farschtschi, Said, et al.
Publicado: (2016)

Malignant Peripheral Nerve Sheath Tumor Arising from Neurofibromatosis
por: Lee, Dae-Sung, et al.
Publicado: (2013)

Quantitative Assessment of Whole-Body Tumor Burden in Adult Patients with Neurofibromatosis
por: Plotkin, Scott R., et al.
Publicado: (2012)

Malignant Peripheral Nerve Sheath Tumors in Children with Neurofibromatosis Type 1
por: Pourtsidis, Apostolos, et al.
Publicado: (2014)

Monitoring scanner calibration using the image-derived arterial blood SUV in whole-body FDG-PET
por: Maus, Jens, et al.
Publicado: (2018)

The effect of post-injection (18)F-FDG PET scanning time on texture analysis of peripheral nerve sheath tumours in neurofibromatosis-1
por: Lovat, Eitan, et al.
Publicado: (2017)

The association of tumor-to-background ratios and SUVmax deviations related to point spread function and time-of-flight F18-FDG-PET/CT reconstruction in colorectal liver metastases
por: Rogasch, Julian MM, et al.
Publicado: (2015)

Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET
por: Hofheinz, Frank, et al.
Publicado: (2019)

Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients
por: Brahmi, Mehdi, et al.
Publicado: (2015)

Intraoral presentation of multiple malignant peripheral nerve sheath tumors associated with neurofibromatosis-1
por: Janardhanan, Mahija, et al.
Publicado: (2011)

Huge Intrathoracic Malignant Peripheral Nerve Sheath Tumor in an Adolescent with Neurofibromatosis Type 1
por: Yoon, Jong Hyung, et al.
Publicado: (2014)

Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumor in the Nasal Cavity
por: Marini, Katerina, et al.
Publicado: (2023)

Metabolic Tumour Burden Measured by (18)F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1
por: Van Der Gucht, Axel, et al.
Publicado: (2016)

Sexual Self-Esteem and Psychological Burden of Adults With Neurofibromatosis Type 1
por: Leidger, Anna, et al.
Publicado: (2022)

Malignant Peripheral Nerve Sheath Tumor of Non-Neurofibromatosis Type I Metastasized to the Cerebrospinal Axis
por: Park, Man-Kyu, et al.
Publicado: (2013)

Intraosseous malignant peripheral nerve sheath tumor of the sacrum in a patient with neurofibromatosis type I
por: Davila, Anthony, et al.
Publicado: (2019)

Deregulated microRNAs in neurofibromatosis type 1 derived malignant peripheral nerve sheath tumors
por: Amirnasr, Azadeh, et al.
Publicado: (2020)

An Unusual Cause of Adrenal Mass in Neurofibromatosis Type 1: Malignant Peripheral Nerve Sheath Tumor
por: Shahait, Awni, et al.
Publicado: (2022)

Cranial nerve and intramedullary spinal malignant peripheral nerve sheath tumor associated with neurofibromatosis-1
por: Newell, Christopher, et al.
Publicado: (2021)

Plexiform neurofibromatosis with peripheral malignant nerve sheath tumor and scoliosis - more surveillance imaging needed?()
por: Kamaludin, Siti Nurhazwani, et al.
Publicado: (2022)

Image-Based Differentiation of Benign and Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1
por: Liu, Jun, et al.
Publicado: (2022)

Limitations and benefits of FDG‐PET/CT in NF1 patients with nerve sheath tumors: A cross‐sectional/longitudinal study
por: Nishida, Yoshihiro, et al.
Publicado: (2021)

Relations between vital capacity, CO diffusion capacity and computed tomographic findings of former asbestos-exposed patients: a cross-sectional study
por: Preisser, Alexandra Marita, et al.
Publicado: (2020)

Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT
por: Park, Jong Sun, et al.
Publicado: (2011)

Malignant Peripheral Nerve Sheath Tumor in Neurofibromatosis Type I : Unusual Presentation of Intraabdominal or Intrathoracic Mass
por: Kim, Jong Gwang, et al.
Publicado: (2005)

Radiation Therapy in Management of Sporadic and Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors
por: Kahn, Jenna, et al.
Publicado: (2014)

Malignant Peripheral Nerve Sheath Tumor of the Inguinum and Angiosarcoma of the Scalp in a Child with Neurofibromatosis Type 1
por: Milković Periša, Marija, et al.
Publicado: (2017)

Neurofibromatosis type I with malignant peripheral nerve sheath tumors in the upper arm: A case report
por: Zhang, Lili, et al.
Publicado: (2019)

Pseudoprogression of Malignant Peripheral Nerve Sheath Tumor in Patient with Neurofibromatosis Type 1, a Case Report
por: Lessing, Andrés J., et al.
Publicado: (2021)

Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma
por: Mattox, Austin K, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nfcr57olr3ikeafrpjbqpev3jj